drugset / Trial / NCT00733304
An Extension to Study MD7108240
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a two month study to allow continued treatment with pazopanib eye drops. Study may be extended to 5 months.
Timeline
- Start
- 2008-06-25
- Primary completion
- 2009-09-09
- Completion
- 2009-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pazopanib | Small molecule | 2 mg/ml | Other |
| Subject | Pazopanib | Small molecule | 5 mg/ml | Other |